(Figure 6) Taken together, ALKBH5 is playing a crucial role in promoting tumour metastasis, and therefore intracellular silencing of ALKBH5 in the TME would hold the potential to control tumor metastasis via increasing the efficacy to anti-PD-1 therapeutics [13]. The gene discussed is PDCD1; the disease is neoplasm.